TABLE 1.
Study ID | Condition a | Study design and participants | Prior risk | Index test | Threshold | Reference standard |
---|---|---|---|---|---|---|
Massively Parallel Shotgun Sequencing (MPSS), N = 15 | ||||||
Bianchi (2012) | 45,X |
|
High |
|
NCV chrom X < −4.0 and NCV chrom Y < 2.5 | Karyotype |
Bianchi (2013) | 45,X |
|
High | Illumina TrueSeq 3.0 sequencing chemistry | NCV chrom X < −3.0 and NCV chrom Y < 3.0 | Karyotype |
Ivashchenko (2019) | 47,XXX |
|
High | Next‐Generation Sequencing | Z‐score <−3 or >3 | Karyotype, FISH |
Jiang (2012) | 45,X, 47,XXY, 47,XYY |
|
High |
Illumina Genome Analyzer IIx or HiSeq 2000 sequencer in multiplex |
t score <−2.5 for 47,XXX and 45,X t score >2.5 for 47,XXY and 47,XYY |
Karyotype |
Lau (2012) | 45,X, 47,XXX, 47XXY, 47,XYY |
|
High | Illumina HiSeq 2000 sequencer in 12‐plex |
Z‐score of [−3.5; −2.5] for 45,X, and 47,XXX ‐Z‐score of [2.5;3.5] for 47,XXY, and 47,XYY |
Karyotype |
Liu (2012) | 45,X, 47,XXX, 47XXY, 47,XYY |
|
High |
Illumina HiSeq sequencer in multiplex |
Z score ≥3 | Karyotype |
Liang (2013) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High | v2 Illumina HiSeq 2000 sequencer in 8‐plex or 12‐ plex |
Z‐score of −2.91 for 45,X, and 47,XXX Z‐score of 3 for 47,XXY, and 47,XYY |
Karyotype |
Lefkowitz (2016) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High |
Illumina HiSeq 2000 sequencer in 6‐plex or uniplex |
Z‐score of [−3.5; −2.5] for 45,X, and 47,XXX Z‐score of [2.5;3.5] for 47,XXY, and 47,XYY |
G‐band karyotype |
Li (2018) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High | BGISEQ‐500 sequencer | Z‐score <−3 or >3 | Karyotype |
Mazloom (2013) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High | Illumina v3 HiSeq 2000 sequencer in 12‐plex |
‐Z‐score of [−3.5; −2.5] for 45,X, and 47,XXX ‐Z‐score of [2.5;3.5] for 47,XXY, and 47,XYY |
Karyotype |
Porreco (2014) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High | Illumina HiSeq 2000 sequencer in 12‐plex |
‐Z‐score of [−3.5; −2.5] for 45,X, and 47,XXX ‐Z‐score of [2.5;3.5] for 47,XXY, and 47,XYY |
Karyotype |
Sehnert (2011) | 45,X |
|
High | Illumina Genome Analyzer IIx sequencer in uniplex | NCV <−3 | Karyotype |
Shaw (2014) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
Mixed | v2 Illumina HiSeq 2000 sequencer in 12‐plex |
Z‐score of [−3.5; −2.5] for 45,X, and 47,XXX ‐Z‐score of [2.5;3.5] for 47,XXY, and 47,XYY |
Karyotype |
Song (2015) |
45,X, 47,XXX, 47,XXY |
|
High | Illumina v2 HiSeq 2000 sequencer in 12‐plex |
Z‐score of −3 for 45,X and 47,XXX ‐Z‐score of 3 for 47,XYY |
Karyotype |
Zhu (2019) |
45,X, 47,XXY |
|
High |
Next‐Generation Sequencing (Ion Proton sequencing) |
Z absolute <1.96 or >3 | Karyotype |
Targeted Massively Parallel Sequencing (TMPS), N = 6 | ||||||
Hooks (2014) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High |
DANSR™ Assay and algorithm (FORTETM) |
NR | Karyotype |
Nicolaides (2013) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High |
SNP‐based Method (NATUS algorithm), Illumina Genome Analyzer IIx or HiSeq sequencer, 19,488‐plex targeted PCR |
NR | Karyotype |
Nicolaides (2014) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High | DANSR™ assay (FORTE), Illumina HiSeq 200 in 96‐plex | FORTE risk score of 1% | Karyotype |
Pergament (2014) | 45,X |
|
Mixed | The Next‐generation Aneuploidy Test Using SNPs algorithm | NR | Karyotype |
Persico (2016) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
High |
SNP‐based Method (NATUS algorithm), Illumina Genome Analyzer IIx or HiSeq sequencer, 19,488‐plex targeted PCR |
A risk score of 1% | Karyotype |
Samango‐Sprouse (2013) | 45,X, 47,XXX, 47,XXY, 47,XYY |
|
Mixed |
SNP‐based Method (NATUS algorithm), Illumina HiSeq sequencer, 19,488‐plex targeted PCR |
NR | Karyotype |
Abbreviation: NCV, normalized chromosome value.
The conditions presented in this review.